Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent Primary CNS Lymphoma

This study has been completed.

Study NCT00082836 Information provided by National Cancer Institute (NCI)

First Received: May 14, 2004 Last Updated: February 6, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given